Evidence map›Paper›PMID 42587092›Full record

ArticleThe EMBO journal2026

Principles of ribosome-associated protein quality control during the synthesis of CFTR.

Tom Joshua Oldfield, Raquel Gonçalves Torres, Romy Enrica Baier, Robin Renn, Débora Broch Trentini

Abstract read
In one paragraph

Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tom Joshua OldfieldUniversity of Cologne, Faculty of Medicine, University Hospital of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.ORCID http://orcid.org/0000-0003-4829-4696
Raquel Gonçalves TorresUniversity of Cologne, Faculty of Medicine, University Hospital of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.ORCID http://orcid.org/0000-0003-4987-0229
Romy Enrica BaierUniversity of Cologne, Faculty of Medicine, University Hospital of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.ORCID http://orcid.org/0009-0006-3762-0467
Robin RennUniversity of Cologne, Faculty of Medicine, University Hospital of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
Débora Broch TrentiniUniversity of Cologne, Faculty of Medicine, University Hospital of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany. d.trentini@uni-koeln.de.ORCID http://orcid.org/0000-0002-2541-4707

Funding

Deutsche Forschungsgemeinschaft (DFG) 540625656Deutsche Forschungsgemeinschaft (DFG) (CRC1678) 520471345Fritz Thyssen Stiftung (Thyssen Foundation) 10.22.2.029MNUzK | Center for Molecular Medicine Cologne, University of Cologne (CMMC, UoC) JRG-05 and CAP-33UzK | Medizinische Fakultät, Universität zu Köln (Faculty of Medicine, University of Cologne) Köln Fortune 376/2021
6 · The paper itself

Abstract

Prolonged translational arrests caused by defective mRNAs activate the ribosome-associated protein quality control (RQC) pathway, which marks harmful incomplete proteins for degradation. Multipass transmembrane proteins have increased propensity to be targeted by the RQC, raising the question of whether problems in transmembrane domain insertion and assembly can also cause RQC-eliciting translational arrests. Here, we investigated RQC-mediated quality control of CFTR, a large transmembrane protein mutated in cystic fibrosis. Reporter assays showed that although a fraction of nascent CFTR expressed in HEK293 cells arrested during translation and activated the RQC, multiple interventions compromising CFTR folding and membrane insertion did not exacerbate this response. CFTR translation abortion was also largely unaffected by regulators of translation kinetics such as codon usage, the ribosome collision sensor GCN1, and the SRP ER targeting complex. We propose that the RQC can be triggered by the inherent difficulties in synthesizing transmembrane segments, resulting from their inappropriate interaction with the protein synthesis machinery. Our study uncovers and characterizes a novel physiological role for the RQC in dealing with elongation-arrested transmembrane proteins.

Indexed as

Cystic Fibrosis Transmembrane Conductance RegulatorProtein BiosynthesisRibosomesHEK293 CellsHumansProtein FoldingCFTR protein, humanCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID42587092
PMCPMC13578226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.